NL-OMON38320已完成2 期
Phase II study of 18 F fluorothymidine Positron Emission Tomography (FLT-PET) in the follow up of glioblastoma multiforme (GBM) patients treated with combined radiotherapie and chemotherapy - Using FLT-PET in the follow up of glioblastoma multiforme patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with histologically confirmed newly diagnosed glioblastoma multiforme (World Health Organization [WHO] grade IV astrocytoma) with indication for radiotherapy and concomitant TMZ followed by adjuvant TMZ.
- •Patients must have clinically and radiographically documented measurable disease. Conventional MRI post surgery must be performed within 28 days prior to start of combined treatment.
- •Absence of inability to undergo MRI or PET scanning
- •Patients >18 years of age
- •WHO performance status of 2 or less
- •Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial
- •Before patient registration/randomization, written informed consent must be given according to ICH/GCP, and national/local regulations.
排除标准
- •Are formulated as 'no existence of' in inclusion criteria
研究者
相似试验
已完成
不适用
Evaluation of 3'-deoxy-3'-[18F]fluorothymidine -PET and diffusion weighted imaging -MRI in patients with early stage non-small cell lung cancer treated with a platinum-based doublet as preoperative chemotherapy.Lungcancer10038666non-small cell lung cancerNL-OMON42040European Organisation for Research in Treatment of Cancer (EORTC)4
进行中（未招募）
不适用
18F-Fluorothymidine Positron Emission Tomography as an early predictor of response to neoadjuvant therapy in patients with locally advanced breast carcinoma - NDBreast carcinoma classified as cT1b,c, T2, T3, or cT4 a-c, cN0-2, N3, M0MedDRA version: 9.1Level: HLTClassification code 10006289EUCTR2010-020472-34-ITISTITUTO EUROPEO DI ONCOLOGIA
已完成
2 期
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone MetastasesHormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate CarcinomaStage IV Prostate CancerNCT00936975National Cancer Institute (NCI)18
已完成
早期 1 期
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical CystectomyUrothelial CarcinomaBladder CancerNCT04018053Brigham and Women's Hospital16
招募中
2 期
Feasibility of FMISO in Brain TumorsMalignant Brain NeoplasmNCT03649880OHSU Knight Cancer Institute50